<DOC>
	<DOCNO>NCT00955539</DOCNO>
	<brief_summary>30 % heart failure patient receive device cardiac resynchronization therapy fail show clinical improvement . The reason lack response still unclear factor scar tissue heart musculature , inadequate lead placement , device-settings degree dyssynchrony implant seem important . In study , factor investigate .</brief_summary>
	<brief_title>Viability Cardiac Resynchronization Therapy</brief_title>
	<detailed_description>Cardiac resynchronization therapy ( CRT ) establish therapy patient severe heart failure , depress leave ventricular function wide QRS-complex . Large clinical trial demonstrate unequivocal improvement functional status , morbidity mortality . However , 30 % heart failure patient treat CRT-device benefit clinically . Several factor suggest important response CRT mechanical dyssynchrony , presence scar tissue myocardium , device-optimization ( among others ) . It purpose study investigate importance factor . 100 patient ischemic cardiomyopathy , eligible CRT accord current guideline , include . Patients randomise two arm . One group atrioventricular ( AV ) -optimization implantation , AV -and interventricular ( VV ) -optimization . After 4 month patient crossed-over arm . Preimplantation patient MR-scanned low-dose dobutamine stress-echocardiography perform . Furthermore patient examine echocardiography evaluation clinical status 1 . Mechanical dyssynchrony predict response CRT . b . Measures mechanical dyssynchrony relate myocardial viability conduction . 2 . Individual optimization base conduction time increase benefit CRT . b . The effect add VV-optimization related myocardial viability . 3 . &gt; 30 % non-viable tissue globally myocardium predictive lack CRT- response . b. Non-viable tissue locate area leave ventricular lead predictive non-response .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Cardiomyopathies</mesh_term>
	<criteria>LVEF &lt; /= 35 % , QRSduration &gt; /= 120 m , NYHAclass II IV . Ischemic heart disease ( &gt; 50 % stenosis 1 major epicardial coronary artery prior PCI CABG . ) Optimal treatment ( betablocker , ACE1 ARB spironolactone ) Pregnancy Unstable angina pectoris Chronical atrial fibrillation Severe valvular disease Dementia mental retardation Severe claustrophobia Acute myocardial infarction &lt; 3 month Severe health condition threaten shortterm survival Severe kidney insufficiency , GFR &lt; 35 ml/min/1.73 m2 Metal implant contraindicative magnetic resonance scan</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Heart Failure</keyword>
	<keyword>Cardiac resynchronization therapy</keyword>
	<keyword>Optimization</keyword>
	<keyword>Viability</keyword>
	<keyword>Mechanical dyssynchrony</keyword>
</DOC>